ASP Isotopes Inc. Files 8-K

Ticker: ASPI · Form: 8-K · Filed: Nov 7, 2025 · CIK: 1921865

Sentiment: neutral

Topics: 8-K, corporate-filing, financials

TL;DR

ASP Isotopes filed an 8-K on Nov 7, 2025, with financial updates.

AI Summary

ASP Isotopes Inc. filed an 8-K on November 7, 2025, reporting under Regulation FD and including financial statements and exhibits. The company, incorporated in Delaware with its principal executive offices in Washington D.C., operates in the miscellaneous chemical products sector.

Why It Matters

This filing indicates routine corporate reporting, providing updates on financial statements and exhibits for ASP Isotopes Inc.

Risk Assessment

Risk Level: low — This filing is a standard 8-K for corporate reporting and does not appear to contain significant new material events.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing by ASP Isotopes Inc.?

The 8-K filing is for Regulation FD Disclosure and includes Financial Statements and Exhibits.

When was this 8-K report filed?

The report was filed on November 7, 2025.

In which state is ASP Isotopes Inc. incorporated?

ASP Isotopes Inc. is incorporated in Delaware.

What is the business address of ASP Isotopes Inc.?

The business address is 601 Pennsylvania Avenue NW, South Building, Suite 900, Washington, DC 20004.

What is the IRS Employer Identification Number for ASP Isotopes Inc.?

The IRS Employer Identification Number is 87-2618235.

Filing Stats: 997 words · 4 min read · ~3 pages · Grade level 12.6 · Accepted 2025-11-07 09:31:29

Key Financial Figures

Filing Documents

01. Regulation FD Disclosure

Item 7.01. Regulation FD Disclosure. On November 7, 2025, Quantum Leap Energy LLC ("QLE"), a wholly-owned subsidiary of ASP Isotopes Inc. (the "Company"), issued an investor presentation that provides an overview of QLE's business. A copy of the investor presentation is attached to this Current Report on Form 8-K as Exhibit 99.1 and is incorporated herein by reference. Also on November 7, 2025, the Company announced that QLE has commenced an offering of QLE convertible promissory notes (the "QLE Notes") in a private placement to accredited investors and to certain non-U.S. persons in transactions outside of the United States in reliance on Regulation S under the Securities Act of 1933 (the "QLE Notes Offering"). QLE has entered into a definitive convertible note purchase agreement with certain investors for an initial closing of $64.3 million of QLE Notes that was led by American Ventures LLC, with the Company also making a significant investment in the QLE Notes. QLE may issue additional QLE Notes in subsequent closings to investors who are non-U.S. persons in transactions outside of the United States in reliance on Regulation S promulgated under the Securities Act of 1933, as amended (the "Securities Act"). A copy of the press release announcing the QLE Notes Offering is attached to this Current Report on Form 8-K as Exhibit 99.2 and is incorporated herein by reference. The information in this Item 7.01, including Exhibits 99.1 and 99.2, shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

Forward-Looking Statements

Forward-Looking Statements All forward-looking statements speak only as of the date hereof. The Company and QLE undertake no obligation to revise or update any forward-looking statements except as

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. Exhibit No. Description 99.1 Corporate Overview of Quantum Leap Energy LLC, dated October 2025. 99.2 Press Release, dated November 7, 2025. 104 Cover Page Interactive Date File (embedded within the Inline XBRL document) 2

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ASP ISOTOPES INC. Date: November 7, 2025 By: /s/ Donald G. Ainscow Name: Donald G. Ainscow Title: Executive Vice President, General Counsel and Secretary 3

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing